The Experts below are selected from a list of 198 Experts worldwide ranked by ideXlab platform

H M Blumberg - One of the best experts on this subject based on the ideXlab platform.

  • Inner-city tuberculosis in the USA.
    The Journal of hospital infection, 1995
    Co-Authors: J E Mcgowan, H M Blumberg
    Abstract:

    Tuberculosis (TB) has become more common during the past five years in several areas of the USA. Occurrence has been facilitated by the increasing number of patients with concurrent HIV infection, by cases due to multiple-drug-resistant strains, by incomplete TB therapy among homeless and non-compliant patients, and by cases in immigrants from other countries where TB prevalence is high. These features mean that the major burden of TB today is being borne by inner-city health care facilities that care for the poor. This is illustrated by data from Atlanta, Georgia, where a large proportion of the new cases recognized in the metropolitan area are reported by Grady Memorial Hospital, the public Hospital serving the indigent and working poor of the inner city. Similar patterns are recognized in the other USA cities where TB has again become a blight. In view of these epidemiological features, minimizing inner-city TB will require careful attention to diagnosis and isolation procedures in the Hospital. Engineering changes at Hospitals providing acute care of TB have recently been ordered by the federal government. These promise to be very expensive, and primarily affect the public Hospitals, which can least afford them. Innovative treatment programmes are essential, as follow-up after acute care is difficult in this setting. Directly observed therapy can help, but for some cases the era of the TB Hospital may have returned. Current attention focuses on legal and ethical issues associated with detaining non-compliant and recalcitrant patients to complete their therapy. Bacille Calmette Guerin (BCG) vaccine is not a priority for this setting at this time.(ABSTRACT TRUNCATED AT 250 WORDS)

  • Inner-city tuberculosis in the USA
    Journal of Hospital Infection, 1995
    Co-Authors: J E Mcgowan, H M Blumberg
    Abstract:

    Tuberculosis (TB) has become more common during the past five years in several areas of the USA. Occurrence has been facilitated by the increasing number of patients with concurrent HIV infection, by cases due to multiple-drug-resistant strains, by incomplete TB therapy among homeless and non-compliant patients, and by cases in immigrants from other countries where TB prevalence is high. These features mean that the major burden of TB today is being borne by inner-city health care facilities that care for the poor. This is illustrated by data from Atlanta, Georgia, where a large proportion of the new cases recognized in the metropolitan area are reported by Grady Memorial Hospital, the public Hospital serving the indigent and working poor of the inner city. Similar patterns are recognized in the other USA cities where TB has again become a blight. In view of these epidemiological features, minimizing inner-city TB will require careful attention to diagnosis and isolation procedures in the Hospital. Engineering changes at Hospitals providing acute care of TB have recently been ordered by the federal government. These promise to be very expensive, and primarily affect the public Hospitals, which can least afford them. Innovative treatment programmes are essential, as follow-up after acute care is difficult in this setting. Directly observed therapy can help, but for some cases the era of the TB Hospital may have returned. Current attention focuses on legal and ethical issues associated with detaining non-compliant and recalcitrant patients to complete their therapy. Bacille Calmette Guerin (BCG) vaccine is not a priority for this setting at this time. New demands also exist for expansion of rapid laboratory techniques. The impact of these requirements on laboratory test volume, technologist time and costs is high, and most laboratories will require new resources to meet the demands. Federal resources to date have aided public health laboratories. Fiscal help is needed as well for Hospital and reference labs where TB is frequently recovered.

Peta De Jager - One of the best experts on this subject based on the ideXlab platform.

J E Mcgowan - One of the best experts on this subject based on the ideXlab platform.

  • Inner-city tuberculosis in the USA.
    The Journal of hospital infection, 1995
    Co-Authors: J E Mcgowan, H M Blumberg
    Abstract:

    Tuberculosis (TB) has become more common during the past five years in several areas of the USA. Occurrence has been facilitated by the increasing number of patients with concurrent HIV infection, by cases due to multiple-drug-resistant strains, by incomplete TB therapy among homeless and non-compliant patients, and by cases in immigrants from other countries where TB prevalence is high. These features mean that the major burden of TB today is being borne by inner-city health care facilities that care for the poor. This is illustrated by data from Atlanta, Georgia, where a large proportion of the new cases recognized in the metropolitan area are reported by Grady Memorial Hospital, the public Hospital serving the indigent and working poor of the inner city. Similar patterns are recognized in the other USA cities where TB has again become a blight. In view of these epidemiological features, minimizing inner-city TB will require careful attention to diagnosis and isolation procedures in the Hospital. Engineering changes at Hospitals providing acute care of TB have recently been ordered by the federal government. These promise to be very expensive, and primarily affect the public Hospitals, which can least afford them. Innovative treatment programmes are essential, as follow-up after acute care is difficult in this setting. Directly observed therapy can help, but for some cases the era of the TB Hospital may have returned. Current attention focuses on legal and ethical issues associated with detaining non-compliant and recalcitrant patients to complete their therapy. Bacille Calmette Guerin (BCG) vaccine is not a priority for this setting at this time.(ABSTRACT TRUNCATED AT 250 WORDS)

  • Inner-city tuberculosis in the USA
    Journal of Hospital Infection, 1995
    Co-Authors: J E Mcgowan, H M Blumberg
    Abstract:

    Tuberculosis (TB) has become more common during the past five years in several areas of the USA. Occurrence has been facilitated by the increasing number of patients with concurrent HIV infection, by cases due to multiple-drug-resistant strains, by incomplete TB therapy among homeless and non-compliant patients, and by cases in immigrants from other countries where TB prevalence is high. These features mean that the major burden of TB today is being borne by inner-city health care facilities that care for the poor. This is illustrated by data from Atlanta, Georgia, where a large proportion of the new cases recognized in the metropolitan area are reported by Grady Memorial Hospital, the public Hospital serving the indigent and working poor of the inner city. Similar patterns are recognized in the other USA cities where TB has again become a blight. In view of these epidemiological features, minimizing inner-city TB will require careful attention to diagnosis and isolation procedures in the Hospital. Engineering changes at Hospitals providing acute care of TB have recently been ordered by the federal government. These promise to be very expensive, and primarily affect the public Hospitals, which can least afford them. Innovative treatment programmes are essential, as follow-up after acute care is difficult in this setting. Directly observed therapy can help, but for some cases the era of the TB Hospital may have returned. Current attention focuses on legal and ethical issues associated with detaining non-compliant and recalcitrant patients to complete their therapy. Bacille Calmette Guerin (BCG) vaccine is not a priority for this setting at this time. New demands also exist for expansion of rapid laboratory techniques. The impact of these requirements on laboratory test volume, technologist time and costs is high, and most laboratories will require new resources to meet the demands. Federal resources to date have aided public health laboratories. Fiscal help is needed as well for Hospital and reference labs where TB is frequently recovered.

William R. Jarvis - One of the best experts on this subject based on the ideXlab platform.

  • The cost of selected tuberculosis control measures at Hospitals with a history of mycobacterium tuberculosis outbreaks
    Infection control and hospital epidemiology, 1997
    Co-Authors: Scott E. Kellerman, Jerome I. Tokars, William R. Jarvis
    Abstract:

    Objective: To determine the cost of nonrespirator-related tuberculosis (TB) control measures at several Hospitals, following publication of the Centers for Disease Control and Prevention (CDC)'s revised TB infection control guidelines. Design: Infection control (IC) and TB coordinators obtained cost information on tuberculin skin-test (TST) programs, addition of IC and employee health service (EHS) personnel, and the retrofit or new construction of environmental controls. Setting: Four Hospitals with, and one community Hospital without, prior nosocomial multidrug-resistant TB transmission. Results: During the study period, the TST program costs remained constant at four of five Hospitals and increased at one Hospital (median 1994 TST program cost: $5,568; range, $2,393-$44,902). Additional IC or EHS personnel were hired at four of five Hospitals (median cost increase, $125,500; range, $63,000-$228,000). The median cost of new construction or new equipment purchases (ie, sputum induction booths, ultraviolet lights, or portable high-efficiency particulate air filters) at study Hospitals was $163,000 (range, $45,000-$524,000) and $70,000 (range, $31,000-$93,000), respectively. Conclusions: Costs associated with implementing control measures similar to those recommended in the CDC TB IC guidelines varied widely by Hospital. Engineering controls involved the largest capital outlay, but increases in personnel were the largest continuing cost. These costs represent improvements made to upgrade selected aspects of Hospital TB control programs, not the cost of an optimal TB control program.

N. Abuaf - One of the best experts on this subject based on the ideXlab platform.

  • Hospital Engineering of Medical Devices in France
    The Open Medical Devices Journal, 2018
    Co-Authors: Mohamed Moumaris, Jean-michel Bretagne, N. Abuaf
    Abstract:

    Biomedical Engineering handles the organization and functioning of medical devices in the Hospital. This is a strategic function of the Hospital for its balance, development, and growth. This is a major focus in internal and external reports of the Hospital. It's based on piloting of medical devices needs and the procedures of biomedical teams’ intervention. Multi-year projects of capital and operating expenditure in medical devices are planned as coherently as possible with the Hospital's financial budgets. An information system is an essential tool for monitoring medical devices Engineering and relationship with medical services.